Dipole Density Mapping of Typical Atrial Flutter (DDRAMATIC)

November 29, 2017 updated by: Acutus Medical

Dipole Density Right Atrial Mapping and Assessment of Therapy In Cavotricuspid Isthmus Flutter

Study to determine the feasibility of the Acutus Medical System in obtaining data to create Dipole Density Maps of electrical activation in the right atrium in patients with typical atrial flutter.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

3

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hamburg, Germany
        • Universitätsklinikum Hamburg-Eppendorf

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Be aged 18 to 75 years
  2. Be scheduled for ablation of typical atrial flutter (cavotricuspid isthmus dependent)
  3. Be able and willing to give informed consent

Exclusion Criteria:

  1. Have any of the following:

    1.1 Patients with implanted prosthetic, artificial, or repaired cardiac valves in the chamber being mapped.

    1.2 Patients with permanent pacemaker or ICD leads in the chamber being mapped. 1.3Patients with hypercoagulopathy or an inability to tolerate anticoagulation therapy during an electrophysiology procedure.

  2. Require treatment in the left atrium and/or a require a transseptal puncture to access the left atrium during the index procedure
  3. Have had a myocardial infarction within the prior two months
  4. Have had cardiac surgery within the prior three months
  5. Have an intracardiac thrombus
  6. Have clinically significant tricuspid valve regurgitation or stenosis
  7. Have had any cerebral ischemic event (including transient ischemic attacks) in the prior six months
  8. Be pregnant or nursing
  9. Be currently enrolled in any other clinical investigation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acutus Medical System
Proprietary software algorithms will be used generate electrical activation maps based dipole density data acquired by the Acutus Medical Catheter during the procedures. These activation maps will then be applied to a 3D model of the endocardial surface to create a 3D activation map.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Incidence of device-and procedure-related adverse events
Time Frame: 7 days
7 days
The number of patients in which offline construction of pre- and post-treatment activation maps can be completed
Time Frame: 7 days
7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Stephan Willems, MD, Universitätsklinikum Hamburg-Eppendorf

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2014

Primary Completion (Actual)

November 1, 2014

Study Completion (Actual)

November 1, 2014

Study Registration Dates

First Submitted

July 31, 2013

First Submitted That Met QC Criteria

July 31, 2013

First Posted (Estimate)

August 2, 2013

Study Record Updates

Last Update Posted (Actual)

December 2, 2017

Last Update Submitted That Met QC Criteria

November 29, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • CL-AFL-002

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Atrial Flutter

Clinical Trials on Acutus Medical System Mapping

3
Subscribe